CAUTI rates were 83% higher and CLABSI rates were 65% higher in the COVID-19 units compared to the non-COVID-19 units.
Patients with coronavirus disease 2019 (COVID-19) are more at risk of contracting central line-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) than patients not afflicted with the novel coronavirus, according to a study by investigators with Denver Health Medical Center which was unveiled at ID Week. The retrospective cohort study was conducted at a 555-bed safety net hospital where infection rates from urinary catheters and central venous catheters were measured. Investigators compared infection rates from 6 months before the COVID-19 pandemic (October 2019 to March 2020) with infection rates during the initial pandemic phase. The hospital received its first patient infected with SARS-CoV-2 in late March 2020.
Hospital administrators sectioned off a part of the facility (4 units, 125 beds) to be used for patients who had been confirmed to have COVID-19. The other units in the hospital only accepted patients who tested negative for the coronavirus (except for a labor and delivery and a designated mixed unit).
The study states: “Patients hospitalized for suspected or confirmed COVID-19 often require high levels of support, including supplemental oxygen or ventilation, intravenous fluids and pressors, prone positioning, and strict input/output monitoring. Increased utilization of invasive devices such as indwelling urinary catheters and central venous catheters may be needed in this population.” In addition, healthcare providers minimized contact time with patients in the COVID units.
The use of indwelling urinary catheters increased during the initial pandemic stage by 36%, while use of central venous catheters increase by 25% in the same time period. CAUTI rates were 83% higher and CLABSI rates were 65% higher in the COVID-19 units compared to the non-COVID-19 units. In addition, rates for urine cultures were 69% higher and rates for blood cultures 73% higher in the COVID areas.
“Patient care protocols, device utilization and culture ordering all require further investigation,” the study concludes.
In September, Maya Gossman, RN, a vascular nurse and member of Infection Control Today®’s Editorial Advisory Board, wrote about how important working with infection preventionists can be when it comes to containing CLASBIs and CSUTIs.
“Although both vascular access and infection prevention have their own focus, our commonality is in ensuring patients get the care they need while minimizing their chances of nosocomial infections,” Gossman wrote. “Infection preventionists have a wide scope, as infections can be caused by many factors while in the hospital, from medical devices to the hands of the healthcare workers caring for them. Vascular access specialists focus on the devices placed into the bloodstream of patients in order to deliver needed medications, allow access for dialysis, or accurately monitor blood pressure. It is because we know that these devices can be a conduit for life-threatening infectious agents that infection preventionists are vital to our specialty.”
Gossman relates how she and the IP at Stillwater Medical Center, in Stillwater, Oklahoma, worked together when the first COVID-19 patient arrived. The IP oversaw how Gossman inserted a vascular access line while wearing personal protective equipment. It turned out to be a success, but Gossman knew that there would be other COVID-19 patients.
“Less than 24 hours after placing that PICC line I met with our infection control nurse to discuss how the COVID-19 team was going to interact with the vascular access team,” Gossman wrote. “We collaborated to create a plan for best protecting our team of 2 from exposure while also ensuring that our patients were protected from further infection caused by a vascular access device. In addition, the infection control nurse and I met with the directors of the lab, the medical floor, and the intensive care unit to discuss ways to minimize exposure of their staff to the patients with confirmed COVID-19 infection.”
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.